Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
Baroda BNP Paribas Health and Wellness Fund Direct Growth
Baroda BNP Paribas Mutual Fund
45slipping
Latest NAV
₹10.9673
as of 18 Aug 2026
AUM
—
Expense ratio
—
Inception
14 May 2026
FundScore
45/100slipping
Rank #556 of 1015 · top 55%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
2.54%
3M
7.10%
6M
14.68%
1Y
10.83%
3Y CAGR
—
5Y CAGR
—
Since incep.
8.38%
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Large cap35.3%
Mid cap38.9%
Small cap25.7%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 31 Jul 2026.
Sun Pharmaceutical Industries Limited
equity
8.82%
Torrent Pharmaceuticals Limited
equity
8.58%
Divi's Laboratories Limited
equity
6.66%
Lupin Limited
equity
6.46%
IPCA Laboratories Limited
equity
5.72%
Apollo Hospitals Enterprise Limited
equity
5.35%
Laurus Labs Limited
equity
5.24%
Fortis Healthcare Limited
equity
4.55%
AstraZeneca Pharma India Limited
equity
4.05%
Glenmark Pharmaceuticals Limited
equity
3.44%
Dr. Lal Path Labs Limited
equity
3.12%
Mankind Pharma Limited
equity
3.09%
Aurobindo Pharma Limited
equity
3.04%
Aster DM Quality Care Limited
equity
2.53%
Zydus Lifesciences Limited
equity
2.47%
Emcure Pharmaceuticals Limited
equity
2.46%
Abbott India Limited
equity
2.41%
Max Financial Services Limited
equity
2.27%
Acutaas Chemicals Limited
equity
2.15%
Concord Biotech Limited
equity
2.05%
Nephrocare Health Services Ltd
equity
1.74%
Metropolis Healthcare Limited
equity
1.46%
Inventurus Knowledge Solutions Limited
equity
1.42%
Ajanta Pharma Limited
equity
1.40%
Gland Pharma Limited
equity
1.20%
Cipla Limited
equity
1.13%
Dr. Reddy's Laboratories Limited
equity
1.11%
MedPlus Health Services Limited
equity
1.09%
Manipal Health Enterprises Ltd
equity
0.96%
Procter & Gamble Health Limited
equity
0.64%